You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early Squamous Cell Carcinoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Shreveport, Louisiana
  • +3 more
Oct 3, 2023

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Mar 20, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • (no location specified)
May 24, 2023

Regional Nodal Basins and Gene Expression Profiling in Primary

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Ultrasound
  • 40-GEP
  • (no location specified)
Jul 12, 2023

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
  • +4 more
Nov 16, 2023

Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oral Mucositis
  • Alfacalcidol Oral Solution
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
  • (no location specified)
Aug 17, 2023

Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Operable
  • Guangzhou, Guangdong, China
  • +1 more
Sep 4, 2023

Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

Recruiting
  • Head and Neck Squamous Cell Carcinoma
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Aug 22, 2023

    People Living With HIV, Oral and Oropharyngeal Cancer, and

    Not yet recruiting
    • HIV Infections
    • +2 more
    • Group Meeting (Focus Group)
    • Questionnaires
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2023

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Squamous Cell Carcinoma in Fanconi Anemia

      Recruiting
      • Fanconi Anemia
      • Inherited Bone Marrow Failure Syndrome
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

        Active, not recruiting
        • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
        • Bapotulimab (BAY1905254)
        • Bapotulimab (BAY1905254) + Pembrolizumab
        • Tucson, Arizona
        • +7 more
        Jan 12, 2023

        Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Nab paclitaxel
        • +2 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital
        Aug 24, 2023

        Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

        Recruiting
        • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
        Feb 9, 2023

        Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

        Not yet recruiting
        • Cutaneous Squamous Cell Carcinoma
        • +3 more
        • Melbourne, Victoria, Australia
          Peter MacCallum Cancer Centre
        May 17, 2023

        Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

        Not yet recruiting
        • Esophageal Cancer
        • +2 more
        • (no location specified)
        Aug 21, 2023

        Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • (no location specified)
        Aug 28, 2023

        Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Penpulimab injection
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
        Oct 7, 2023

        Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Intensity-modulated radiotherapy (IMRT)
        • +3 more
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 16, 2023

        Esophageal Squamous Cell Carcinoma Trial (XH-30002 capsule, Afatiinb tablet)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • XH-30002 capsule
        • Afatiinb tablet
        • (no location specified)
        Jun 25, 2023

        Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • +2 more
        • Marlborough, Massachusetts
          Phio Pharmaceuticals Corp.
        Aug 25, 2023

        Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • Cadonilimab combined Anlotinib
        • Hangzhou, Zhejiang, China
          2nd Affiliated Hospital, School of Medicine, Zhejiang University
        Aug 6, 2023